Stay updated with breaking news from Leo Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tobii Dynavox AB , Reg. No. 556914-7563, hereby gives notice to attend the annual general meeting on 3 May 2024 at 09.30 CEST in the premises of Advokatfirman Vinge at Smålandsgatan 20, SE-114 46...
Upadacitinib trials in atopic dermatitis have included diverse patient groups with varying risk factors, according to Dr Christopher Bunick.
It is the first treatment for pediatric patients with moderate-to-severe atopic dermatitis that specifically targets the interleukin (IL)-13 cytokine.
Discover Timber Pharmaceuticals' Chapter 11 bankruptcy filing and their